about
The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound HealingMicroRNAs in Diabetic Kidney DiseaseRepression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathyUrinary exosomal microRNAs in incipient diabetic nephropathy.High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression.MicroRNAs and diabetic complicationsMicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.TGF-β induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy.Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathyMicroRNAs: potential mediators and biomarkers of diabetic complications.FOG2 protein down-regulation by transforming growth factor-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy.Stability of miRNA in human urine supports its biomarker potential.MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.From -omics to personalized medicine in nephrology: integration is the key.Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.MicroRNAs: potential regulators of renal development genes that contribute to CAKUT.Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.microRNAs in Diabetic Kidney Disease.Towards microRNA-based therapeutics for diabetic nephropathy.Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.An inducible mouse model of podocin-mutation-related nephrotic syndrome.
P2860
Q26827627-E6C034A6-59A3-41A9-85FD-CD3C1ABC8C00Q27002171-78352375-D217-4993-9ABF-0E87673ED84FQ34726882-C882B2E7-5C8E-4544-9466-821FF25AE73CQ35035283-93C9FB30-6E60-4D7F-8995-581118267A1AQ35040588-5064C729-9AA9-4828-8AEE-85264F36E5EAQ35625038-30BFB3E4-BB2B-4899-AF99-9706A905FF25Q36094855-181062C0-2FCA-4C4C-AC38-AF4E09385A0EQ36166755-2E6E3F55-8FFD-4461-994C-362AC4140D38Q37045293-5CFD0A06-376E-4DD6-BE69-65F595F41691Q37110591-7098FC61-D8BC-476D-A304-A11B9538CEF7Q37146727-0BCB9842-4287-4A4C-BE7E-60AE88ED93BAQ37311890-101161A2-8F53-4A95-904F-59AAD71E7BA4Q37450795-EC359E2B-DEDA-47B1-9883-987421850A6DQ38050081-AD9CCF44-0BC6-404F-A747-C0320EB66C35Q38066427-8892AA5C-2CCB-4885-9C86-A2D0C34E7B95Q38105995-914B6121-F6F6-451A-9543-FED263A74961Q38133419-8F02CAA0-C34B-4E8C-9892-156622B22AE6Q38205150-7DF4248F-5572-4886-BC5F-F46DB332D76FQ38289926-05791E72-C3C1-490F-9003-48950A7CF20BQ38668261-C69DAA0A-1C0E-4C59-A122-14D33364E400Q39523597-D80A5ED0-F5E0-4BD6-8E13-BF58C33C79A8Q39847763-4C2EE8EB-EAB0-4646-8AF7-2C32EE377454Q43410167-0D1A30BE-2B88-41F7-8DAA-11D6300BA70C
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MicroRNAs and the glomerulus
@ast
MicroRNAs and the glomerulus
@en
type
label
MicroRNAs and the glomerulus
@ast
MicroRNAs and the glomerulus
@en
prefLabel
MicroRNAs and the glomerulus
@ast
MicroRNAs and the glomerulus
@en
P2093
P2860
P1476
MicroRNAs and the glomerulus
@en
P2093
Jung Tak Park
Mitsuo Kato
Rama Natarajan
P2860
P304
P356
10.1016/J.YEXCR.2012.02.034
P407
P577
2012-03-05T00:00:00Z